Oluguric Child

Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. It is not a substitute for professional clinical judgment, diagnosis, or treatment. Clinicians must always consider individual patient circumstances, local protocols, and the most current evidence-based guidelines.

Overview

• Definition: Oliguria in a child refers to abnormally low urine output for their age and weight. Specific definitions vary slightly but generally include:
  • Infants (<1 year): Urine output < 1 mL/kg/hour
  • Children (>1 year): Urine output < 0.5 mL/kg/hour
  • Severe oliguria/Anuria: Urine output < 0.3 mL/kg/hour or no urine for 12-24 hours. Oliguria is often the earliest and most reliable sign of acute kidney injury (AKI) or severe dehydration/hypovolemia.
• Epidemiology: Acute kidney injury (AKI) in children, frequently presenting with oliguria, is a significant problem, particularly in hospitalized or critically ill patients.
  • Incidence in hospitalized children ranges from 2-18%.
  • Incidence in pediatric intensive care units (PICUs) can be as high as 30-50%.
  • Sepsis, hypovolemia, cardiac surgery, and nephrotoxic medications are leading causes.
• Classification: Oliguria typically reflects underlying acute kidney injury (AKI), which is broadly classified by its etiology:
  • Prerenal AKI: Due to decreased renal perfusion (e.g., dehydration, hemorrhage, sepsis, heart failure) without intrinsic kidney damage. This is the most common cause in children.
  • Intrinsic Renal AKI: Due to direct damage to the kidney parenchyma (e.g., acute tubular necrosis (ATN), glomerulonephritis, hemolytic-uremic syndrome (HUS), acute interstitial nephritis).
  • Postrenal AKI (Obstructive Nephropathy): Due to obstruction of urine flow anywhere from the renal pelvis to the urethra (e.g., posterior urethral valves, kidney stones, strictures, neurogenic bladder).

Pathophysiology

• Mechanism:
  • Prerenal AKI: Reduced effective circulating volume or renal blood flow leads to decreased glomerular filtration rate (GFR). The kidney initially attempts to compensate by increasing reabsorption of sodium and water (leading to concentrated urine with low sodium) and constricting renal afferent arterioles. Prolonged or severe hypoperfusion can lead to ischemic injury and progression to intrinsic AKI (ATN).
  • Intrinsic Renal AKI:
    • Acute Tubular Necrosis (ATN): Most common intrinsic cause. Ischemic (prolonged prerenal state, shock) or nephrotoxic (medications, toxins) insults damage tubular epithelial cells, leading to decreased reabsorption and filtration. Sloughing of necrotic cells can obstruct tubules.
    • Glomerulonephritis: Inflammation and damage to glomeruli impair filtration.
    • Hemolytic-Uremic Syndrome (HUS): Microvascular endothelial damage leads to microangiopathic hemolytic anemia, thrombocytopenia, and AKI.
  • Postrenal AKI: Increased intratubular pressure proximal to the obstruction impairs GFR. Prolonged obstruction can lead to parenchymal atrophy.
• Risk Factors:
  • Volume Depletion: Vomiting, diarrhea, poor oral intake, hemorrhage, burns, third-spacing (e.g., sepsis, pancreatitis).
  • Systemic Illnesses: Sepsis, severe infection, cardiogenic shock, liver failure, congenital heart disease (especially post-cardiac surgery).
  • Nephrotoxic Medications: Aminoglycosides (e.g., gentamicin), NSAIDs, ACE inhibitors/ARBs, contrast agents, vancomycin, certain chemotherapeutic agents (e.g., cisplatin, methotrexate).
  • Renal/Urinary Tract Anomalies: Posterior urethral valves, hydronephrosis, solitary kidney, neurogenic bladder.
  • Specific Syndromes: Hemolytic-Uremic Syndrome (HUS), severe rhabdomyolysis, tumor lysis syndrome.
  • Pre-existing Chronic Kidney Disease (CKD).
• Protective Factors:
  • Adequate Hydration: Especially during illness or strenuous activity.
  • Judicious Use of Nephrotoxic Medications: Avoiding unnecessary use, dose adjustment, therapeutic drug monitoring.
  • Early Recognition and Treatment of Sepsis/Shock: Prompt fluid resuscitation and vasopressor support.
  • Careful Monitoring: Close monitoring of fluid balance, urine output, and renal function in high-risk patients.

Clinical Presentation

Signs and Symptoms

• Cardinal Features:
  • Decreased Urine Output: The most direct and cardinal sign. Parents may report "wetting fewer diapers" or "not peeing much."
  • Lethargy/Irritability: Signs of systemic illness or metabolic derangements.
• Early Signs:
  • Thirst (in older children), dry mucous membranes, decreased skin turgor (signs of dehydration).
  • Mild Tachycardia.
  • Sunken fontanelle (infants).
  • Poor feeding/anorexia.
• Advanced Signs:
  • Fluid Overload: Peripheral edema (puffy face, swollen extremities), periorbital edema, pulmonary edema (tachypnea, crackles, increased work of breathing), ascites, hepatomegaly.
  • Electrolyte Imbalances: Muscle weakness, arrhythmias (due to hyperkalemia), seizures (due to severe hyponatremia/hypernatremia, uremia).
  • Metabolic Acidosis: Kussmaul respirations (deep, labored breathing).
  • Hypertension: Due to fluid overload or renal parenchymal disease.
  • Uremic Symptoms: Nausea, vomiting, confusion, asterixis, uremic frost (rare).
• Atypical Presentations:
  • "Non-Oliguric" AKI: Renal injury can occur without significant decrease in urine output, especially with certain nephrotoxins or conditions like acute interstitial nephritis. Elevated creatinine may be the only initial clue.
  • Normal urine output but significantly increased specific gravity: Can indicate early dehydration before frank oliguria.

Physical Examination

• Inspection:
  • General Appearance: Alertness, distress, level of consciousness (lethargy, irritability).
  • Hydration Status: Sunken eyes/fontanelle (infants), dry mucous membranes, decreased tear production, absence of axillary sweat.
  • Edema: Periorbital, peripheral (hands, feet), sacral, generalized anasarca.
  • Respiratory Status: Tachypnea, increased work of breathing (retractions, flaring) suggestive of pulmonary edema or metabolic acidosis.
  • Skin: Pallor (anemia), rash (vasculitis, HUS), petechiae/purpura (DIC, HUS), capillary refill time.
  • Abdomen: Distention (fluid overload, ascites, bladder distention).
• Palpation:
  • Skin Turgor: Assess over the abdomen or forearm; decreased turgor indicates dehydration.
  • Peripheral Pulses: Weak or thready pulses (hypovolemia).
  • Capillary Refill Time: Prolonged (>2 seconds) suggests poor perfusion.
  • Abdominal Palpation: Palpable bladder (postrenal obstruction), enlarged kidneys (hydronephrosis, polycystic kidney disease), tenderness.
  • Hepatomegaly: May indicate fluid overload or systemic disease.
• Special Tests:
  • Orthostatic Vital Signs: In older cooperative children, though rarely safe or practical in children presenting with significant oliguria.
  • Fundoscopy: May reveal hypertensive retinopathy.

Diagnostic Approach

History Taking

• Key Questions:
  • Quantity of Urine Output: Exact number of wet diapers (for infants/toddlers) or frequency/volume of voiding (for older children). When was the last void?
  • Fluid Intake: Oral intake (vomiting, diarrhea, poor feeding), IV fluids received.
  • Recent Illnesses: Fever, vomiting, diarrhea, rashes, sore throat, systemic infections.
  • Medications: Recent or current use of nephrotoxic drugs (NSAIDs, antibiotics, ACE inhibitors, contrast). Over-the-counter medications.
  • Pre-existing Conditions: Cardiac disease, chronic kidney disease, congenital anomalies, diabetes.
  • Recent Trauma/Surgery: Especially cardiac surgery or major abdominal surgery.
  • Voiding Pattern Changes: Dysuria, frequency, hesitancy, weak stream, history of UTIs.
  • Family History: Kidney disease, deafness, autoimmune disorders.
• Red Flags:
  • Rapidly Decreasing Urine Output: Especially with signs of shock.
  • Anuria: No urine for 12-24 hours.
  • Signs of Fluid Overload: Respiratory distress, severe edema.
  • Severe Electrolyte Imbalance Symptoms: Arrhythmias, seizures, altered mental status.
  • Signs of Sepsis: Fever, lethargy, poor perfusion, shock.
  • History of Hematuria, Purpura, Abdominal Pain: Suggestive of HUS, vasculitis.

Laboratory Tests

• First-Line:
  • Complete Metabolic Panel (CMP):
    • Serum Creatinine: Most important marker of GFR. Trend is crucial. Note: Baseline creatinine varies by age, sex, and muscle mass. A "normal" value may still indicate significant loss of kidney function if it's a recent increase for that child.
    • Blood Urea Nitrogen (BUN): Rises with decreased GFR and also with increased protein catabolism, GI bleed.
    • Electrolytes (Na, K, Cl, HCO3): To assess for hyperkalemia, hyponatremia, hypernatremia, and metabolic acidosis.
    • Glucose: To rule out osmotic diuresis or severe hypoglycemia.
  • Urinalysis with Microscopy:
    • Specific Gravity: High (>1.020) suggests prerenal azotemia/dehydration. Low (<1.010) suggests intrinsic renal dysfunction (inability to concentrate urine).
    • Proteinuria: May indicate glomerular disease.
    • Hematuria: Glomerulonephritis, HUS, UTI, stones, trauma.
    • Casts:
      • Hyaline casts: Non-specific, can be seen with dehydration.
      • Granular/Epithelial/Muddy brown casts: Characteristic of ATN.
      • Red cell casts: Glomerulonephritis.
      • White cell casts: Pyelonephritis, interstitial nephritis.
  • Urine Electrolytes:
    • Urine Sodium (UNa): Low (<20 mEq/L) in prerenal AKI (kidney trying to conserve sodium). High (>40 mEq/L) in intrinsic AKI (kidney unable to reabsorb sodium).
    • Fractional Excretion of Sodium (FeNa): Best indicator to differentiate prerenal from intrinsic AKI when not on diuretics.
      • FeNa = [(Urine Na * Plasma Cr) / (Plasma Na * Urine Cr)] * 100
      • Prerenal AKI: FeNa < 1% (in term neonates, < 2.5-3%)
      • Intrinsic AKI (ATN): FeNa > 2% (in term neonates, > 2.5-3%)
      • Caution: FeNa can be misleading in specific conditions (e.g., contrast nephropathy, rhabdomyolysis, AKI on CKD, diuretic use).
• Confirmatory: Depends on suspected etiology.
  • Urine Output Monitoring: Strict hourly urine output (UOP) with a Foley catheter (if clinically indicated) is essential.
  • Complete Blood Count (CBC): Anemia (CKD, HUS), thrombocytopenia (HUS, DIC), leukocytosis (infection).
  • Coagulation Studies (PT/PTT/INR): If bleeding diathesis or sepsis suspected.
  • Blood Gas (ABG/VBG): To assess metabolic acidosis and oxygenation.
  • Inflammatory Markers (CRP, Procalcitonin): To assess for infection/sepsis.
  • Specific Serologies/Tests (if indicated):
    • HUS panel: Shiga toxin (STEC O157:H7), ADAMTS13 activity (atypical HUS).
    • Glomerulonephritis workup: ANA, C3/C4 complement, ASO, anti-DNAse B, anti-GBM, ANCA.
    • Myoglobin/CK: Suspected rhabdomyolysis.
    • Drug levels: For nephrotoxic drugs (e.g., vancomycin, aminoglycosides).
• Monitoring:
  • Daily or more frequent BUN, Creatinine, Electrolytes: To track renal function and electrolyte balance.
  • Strict Fluid Balance: All input and output.
  • Daily Weights: Best indicator of fluid status.
  • Vital Signs: BP, HR, RR, SpO2.

Imaging

• Recommended:
  • Renal Ultrasound (Kidney, Ureter, Bladder - KUB): First-line imaging.
    • Assesses kidney size, shape, echogenicity.
    • Crucially, identifies hydronephrosis (dilation of renal pelvis and calyces) suggestive of postrenal obstruction.
    • Evaluates for bladder distention, renal stones, congenital anomalies, polycystic kidney disease.
    • Assesses renal blood flow via Doppler (if available and operator dependent).
• Advanced:
  • Voiding Cystourethrogram (VCUG): If posterior urethral valves or vesicoureteral reflux (VUR) are suspected after initial stabilization and infection control.
  • CT Urogram/MRI Urogram: Rarely needed acutely, but can provide more detailed anatomical information if obstruction is suspected but not clearly visualized on ultrasound, or for complex anomalies. Avoid contrast if possible in AKI.
  • Renal Scintigraphy (DMSA or DTPA scan): To assess differential renal function or identify renal scarring, typically performed once acute phase has resolved.
  • Kidney Biopsy: Gold standard for diagnosing specific intrinsic renal diseases (e.g., glomerulonephritis, acute interstitial nephritis) when the etiology is unclear and prognosis/management depend on a definitive diagnosis. Not usually performed acutely unless rapidly progressive glomerulonephritis is suspected and immediate immunosuppression is considered.

Management

Acute Management

The primary goals are to identify and treat the underlying cause, prevent further kidney damage, manage fluid and electrolyte imbalances, and provide supportive care. - Immediate (First-hour interventions): * Assess ABCs: Airway, Breathing, Circulation. Address any compromise. * Establish IV Access: For fluid administration and blood draws. * Assess Hydration Status: Clinical assessment is key. * Strict Urine Output Monitoring: Place a Foley catheter if UOP cannot be accurately measured (e.g., anuric, unconscious, critically ill). * Initial Labs: Send first-line labs (CMP, Urinalysis). * Stat Renal Ultrasound: If obstruction is suspected or cause of oliguria is unclear. - Stabilization (Early management priorities): * Address Hypovolemia/Shock (Prerenal AKI): * Fluid Challenge: If clinical signs of dehydration/hypovolemia are present and no signs of fluid overload, administer intravenous boluses of isotonic crystalloids (e.g., 0.9% NaCl or Lactated Ringer's) at 10-20 mL/kg over 10-20 minutes. Reassess after each bolus. Caution: In oliguric patients, repeat boluses must be administered extremely cautiously with close monitoring for signs of fluid overload (e.g., crackles, hepatomegaly, increased work of breathing). Stop fluid challenge if no increase in UOP or signs of overload develop. * Vasopressors: If shock persists despite adequate fluid resuscitation. * Discontinue Nephrotoxic Agents: Review all medications and discontinue or adjust doses of nephrotoxic drugs. * Relieve Obstruction (Postrenal AKI): If hydronephrosis is identified, emergent urological consultation for catheterization, nephrostomy tube, or stent placement to relieve obstruction. * Manage Electrolyte Imbalances: * Hyperkalemia: * ECG monitoring: For peaked T waves, prolonged PR, wide QRS, sine wave. * Acute lowering: Calcium gluconate (0.5 mL/kg IV over 5-10 min, max 10 mL) for cardiac membrane stabilization. * Shift K+ intracellularly: Insulin (0.1 units/kg IV) with glucose (0.5-1 g/kg IV), albuterol (2.5-5 mg nebulized). * Remove K+: Furosemide (if still making urine), potassium-binding resins (e.g., sodium polystyrene sulfonate - Kayexalate), hemodialysis/CRRT. * Hyponatremia: Fluid restriction (if hypervolemic hyponatremia). Hypertonic saline (3% NaCl) for symptomatic hyponatremia (seizures, altered mental status) at 2-4 mL/kg slowly over 20-30 min, target increase 4-6 mEq/L in first few hours, total increase <10-12 mEq/L/24h. * Metabolic Acidosis: Bicarbonate supplementation generally reserved for severe acidosis (pH <7.1-7.2) or symptomatic acidosis. * Diuretics: Furosemide (1-5 mg/kg IV) can be attempted only if volume overloaded to promote urine flow. If no response to high-dose furosemide, it may indicate severe ATN or progression to anuric renal failure, signaling potential need for renal replacement therapy. - Emergency: * Indications for Renal Replacement Therapy (RRT - Dialysis/CRRT): * Refractory fluid overload (especially pulmonary edema). * Refractory hyperkalemia. * Severe metabolic acidosis unresponsive to medical therapy. * Uremic encephalopathy, pericarditis, or neuropathy. * Severe electrolyte disturbances (e.g., symptomatic hyponatremia/hypernatremia). * Poisoning with dialyzable toxins.

Chronic Management

Management depends on the underlying cause of AKI and whether kidney function fully recovers. - Pharmacological: * Fluid and Electrolyte Management: Often includes phosphate binders (if hyperphosphatemia), calcitriol (if vitamin D deficient), bicarbonate (if persistent acidosis). * Antihypertensives: ACE inhibitors/ARBs or calcium channel blockers for chronic hypertension. * Erythropoietin-stimulating agents: For chronic anemia of kidney disease. * Immunosuppressants: For specific glomerular diseases if indicated. - Non-pharmacological: * Nutritional Support: Adequate calories and protein. Restriction of fluid, sodium, potassium, and phosphorus as needed. Dietary counseling is crucial. * Growth Monitoring: Close attention to growth in children with ongoing CKD. * Vaccinations: Ensure up-to-date vaccinations, including Pneumococcal and Hepatitis B. * Psychosocial Support: For patient and family. - Monitoring: * Regular follow-up: With a pediatric nephrologist. * Serial measurements: Of BUN, creatinine, GFR (estimated), electrolytes, acid-base status, CBC, calcium, phosphate, PTH. * Blood pressure monitoring: At every visit. * Urinalysis and urine protein-to-creatinine ratio: For proteinuria monitoring. * Growth and developmental assessments.

Treatment Algorithms

Algorithm for Oliguria in a Child (Simplified)

1. Assess Urine Output & Vital Signs:

   • Oliguria defined: <1 mL/kg/hr (infants), <0.5 mL/kg/hr (children).
   • Assess for signs of shock (tachycardia, poor perfusion, hypotension).
   • If Anuric (no UOP > 12-24 hrs) or Shock: Emergency! Stabilize, consider RRT, urology consult if obstruction suspected.

2. Initial Workup:

   • History: Fluid intake/output, recent illness, medications.
   • Physical Exam: Hydration status, signs of fluid overload, palpable bladder.
   • Labs: BUN, Cr, electrolytes, UA, UNa, UCr (for FeNa).
   • Imaging: Renal ultrasound (stat if obstruction suspected).

3. Differentiate AKI Type:

   • Prerenal AKI:
     • Clinical: Signs of dehydration (dry membranes, poor turgor, low BP/tachycardia), no edema.
     • Labs: BUN/Cr ratio >20:1, FeNa <1% (<2.5% in neonates), high urine specific gravity (>1.020).
     • First-Line Treatment: Fluid resuscitation (10-20 mL/kg IV bolus, repeat cautiously).
   • Intrinsic Renal AKI:
     • Clinical: May have edema, hypertension, specific systemic signs (e.g., rash, purpura).
     • Labs: BUN/Cr ratio <20:1, FeNa >2% (>2.5% in neonates), low urine specific gravity (<1.010), muddy brown casts (ATN), RBC casts (GN).
     • First-Line Treatment: Address underlying cause (e.g., stop nephrotoxins, manage HUS/GN). Fluid restriction (often starting with 2/3 maintenance fluid + replacement of insensible losses), careful management of electrolytes. Diuretics (furosemide) only if fluid overloaded.
   • Postrenal AKI (Obstructive):
     • Clinical: Bladder distention, abdominal pain, history of urinary symptoms, specific anomalies.
     • Labs: Can mimic prerenal initially (FeNa <1%) if acute obstruction, or intrinsic (FeNa >2%) if prolonged.
     • Imaging: Hydronephrosis on renal ultrasound.
     • First-Line Treatment: Urgent relief of obstruction (Foley catheter, urology consult for drainage).

4. Monitoring:

   • Strict hourly UOP, daily weights, serial BUN/Cr, electrolytes.

5. Refractory Cases / Indications for RRT:

   • Fluid overload refractory to diuretics.
   • Severe hyperkalemia refractory to medical management.
   • Severe metabolic acidosis refractory to medical management.
   • Uremic complications (encephalopathy, pericarditis).
   • Second-Line Treatment: Renal Replacement Therapy (RRT - peritoneal dialysis, hemodialysis, CRRT).

Complications

• Common:
  • Fluid Overload: Peripheral and pulmonary edema, hypertension.
  • Electrolyte Disturbances: Hyperkalemia (life-threatening), hyponatremia, hypernatremia, hyperphosphatemia, hypocalcemia.
  • Metabolic Acidosis.
  • Anemia.
• Serious:
  • Cardiac Arrhythmias: Secondary to hyperkalemia.
  • Pulmonary Edema: Leading to respiratory failure.
  • Hypertensive Encephalopathy: Due to severe uncontrolled hypertension.
  • Seizures: Due to severe electrolyte imbalances (hyponatremia, hypernatremia, uremia) or hypertensive encephalopathy.
  • Uremic Pericarditis/Encephalopathy: Indications for urgent dialysis.
  • Sepsis: Both a cause and complication of AKI.
• Long-term:
  • Chronic Kidney Disease (CKD): AKI, particularly severe or recurrent episodes, significantly increases the risk of developing new or progressive CKD.
  • End-Stage Kidney Disease (ESKD): Requiring long-term dialysis or kidney transplantation.
  • Hypertension.
  • Proteinuria.
  • Growth Retardation.
  • Neurocognitive deficits.

Prognosis

• Factors:
  • Etiology of AKI: Prerenal AKI generally has the best prognosis with prompt fluid resuscitation. Intrinsic AKI (e.g., severe ATN, HUS, severe glomerulonephritis) and prolonged postrenal obstruction have higher morbidity/mortality.
  • Severity of AKI: Higher peak creatinine, need for RRT, and prolonged anuria are associated with worse outcomes.
  • Presence of Comorbidities: Sepsis, multi-organ failure, pre-existing CKD, and congenital anomalies worsen prognosis.
  • Age: Young infants and neonates are particularly vulnerable.
  • Timeliness and Appropriateness of Management: Early diagnosis and aggressive, appropriate management improve outcomes.
• Survival:
  • Overall mortality for AKI in hospitalized children ranges from 10-30%, higher in PICU (up to 60% in some severe cases).
  • Mortality is significantly higher if RRT is required.
• Quality of Life:
  • Even with recovery of renal function, children who experience AKI are at increased risk for future CKD, hypertension, and proteinuria, which can impact long-term health and quality of life.
  • Some children experience ongoing need for medication, dietary restrictions, and frequent medical appointments.

Prevention

• Primary: Preventing initial occurrence of AKI.
  • Maintain Adequate Hydration: Especially during illness, fever, vomiting, or diarrhea.
  • Judicious Use of Nephrotoxic Medications:
    • Avoid unnecessary use, especially NSAIDs in volume-depleted patients.
    • Dose adjustment for renal impairment.
    • Therapeutic drug monitoring for agents like aminoglycosides.
    • Hydration before and after contrast administration in high-risk patients.
  • Early Recognition and Treatment of Sepsis/Shock: Prompt fluid resuscitation and appropriate antimicrobial therapy.
  • Control Underlying Diseases: Good management of diabetes, heart failure, etc.
• Secondary: Early detection and intervention to prevent progression or reduce severity.
  • Close Monitoring of High-Risk Patients: Critically ill, post-surgery, or those on nephrotoxic drugs. Strict fluid balance and daily weights.
  • Prompt Evaluation of Oliguria: As outlined in the diagnostic approach.
  • Early Intervention: With fluid resuscitation for dehydration or relief of obstruction.
• Tertiary: Preventing complications and long-term sequelae.
  • Optimal Management of AKI: To minimize kidney damage and promote recovery.
  • Long-term Follow-up: With a pediatric nephrologist for any child with a significant AKI episode, even if renal function normalizes.
  • Education: For families about signs of recurrent AKI or CKD.

Special Populations

• Pediatric:
  • Neonates/Infants:
    • Higher percentage of total body water, higher insensible losses, lower GFR (especially preterm).
    • Kidneys are less able to concentrate or dilute urine and less able to handle solute loads compared to older children/adults.
    • FeNa interpretation differs (<2.5-3% considered prerenal).
    • Fluid management is more delicate; smaller margins for error.
    • Congenital anomalies (e.g., posterior urethral valves) are more common causes of AKI.
  • Adolescents: May present more like adults (e.g., recreational drug use, eating disorders causing dehydration).
• Geriatric: Not directly applicable as the topic is "Oliguric Child".
• Pregnancy: Not directly applicable as the topic is "Oliguric Child".
• Comorbidities:
  • Congenital Heart Disease (CHD): Especially post-cardiac surgery, common cause of AKI due to low cardiac output, bypass, and inflammation. Fluid management is very challenging.
  • Sepsis: AKI is a common and severe complication, often multifactorial (hypoperfusion, inflammation, nephrotoxic drugs).
  • Chronic Kidney Disease (CKD): Patients with pre-existing CKD are more susceptible to AKI (often called AKI on CKD), which can accelerate CKD progression.
  • Bone Marrow Transplant Patients: High risk of AKI due to conditioning regimens, infection, and multi-organ dysfunction.

Clinical Pearls

• Diagnostic:
  • Always suspect dehydration/hypovolemia first in an oliguric child unless proven otherwise. A well-conducted fluid challenge is often both diagnostic and therapeutic for prerenal AKI.
  • FeNa is a powerful tool, but be aware of its limitations (e.g., diuretic use, CKD).
  • "Normal" creatinine in a very young infant or a child with significant muscle wasting may still represent significant AKI. Trend of creatinine is more important than a single absolute value.
  • Don't forget postrenal causes! A quick renal ultrasound can save a kidney from permanent damage.
• Treatment:
  • Fluid management is a tightrope walk in oliguric patients. Too little, and you worsen ischemia; too much, and you cause fluid overload (pulmonary edema, hypertension). Clinical assessment (daily weights, vital signs, edema) is paramount.
  • Hyperkalemia is an emergency. Always check an ECG. Calcium gluconate is for cardiac stability, not for lowering K+. Insulin/glucose and albuterol shift K+; Kayexalate and dialysis remove K+.
  • Stop all non-essential nephrotoxic medications immediately.
  • Diuretics (furosemide) should generally only be used in oliguric patients if there is evidence of fluid overload. They do not "fix" kidney function and can worsen volume depletion if used inappropriately.
• Pitfalls:
  • Over-resuscitation: Leading to fluid overload, especially in intrinsic renal AKI or patients with cardiac dysfunction.
  • Missing obstruction: Failure to perform renal ultrasound promptly.
  • Delayed recognition of AKI: Not monitoring urine output in at-risk children.
  • Assuming oliguria is always due to dehydration: Without considering intrinsic or postrenal causes.
  • Aggressive correction of hyponatremia: Risking osmotic demyelination syndrome.
  • Ignoring a "normal" creatinine level: In a child who previously had a lower baseline.

Recent Updates

• Guidelines: The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for AKI (2012, with recent updates/commentaries) provide comprehensive, evidence-based recommendations for diagnosis, risk assessment, and management of AKI in both children and adults. The Acute Kidney Injury Network (AKIN) and Pediatric Risk, Injury, Failure, Loss, End-stage kidney disease (pRIFLE) / Kidney Disease: Improving Global Outcomes (KDIGO) criteria are now widely accepted for diagnosing and staging AKI severity in children based on serum creatinine changes and urine output.
• Evidence:
  • Increased recognition of the long-term consequences of even mild AKI in children, emphasizing the need for follow-up.
  • Ongoing research into biomarkers for early AKI detection (e.g., NGAL, KIM-1, IL-18) before creatinine rises, though their routine clinical use is still evolving.
  • Growing evidence supports restrictive fluid management in critically ill children, particularly those with fluid overload, and earlier consideration of RRT for fluid refractory AKI.
  • Focus on "renal protective bundles" in critical care settings to prevent AKI (e.g., avoiding nephrotoxins, optimizing hemodynamics, strict fluid balance).
• Controversies:
  • Optimal timing and modality of RRT initiation in pediatric AKI: Still an area of active debate and research.
  • Role of specific fluid types (e.g., balanced crystalloids vs. saline) in preventing/treating AKI in children.
  • Universal applicability of FeNa in all pediatric AKI settings, especially in neonates or patients with pre-existing CKD.

Key References

• Guidelines:
  • Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):1-138. (And subsequent updates/commentaries)
  • Akcan-Arikan A, Zappitelli A, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71(10):1028-1035. (pRIFLE criteria)
• Studies:
  • Select studies on AKI epidemiology and outcomes in PICUs (e.g., AWARE study - Assessment of Worldwide AKI, NEOCLIP study in neonates).
  • Research on novel biomarkers for AKI in pediatric populations.
• Reviews:
  • UpToDate topics on "Acute kidney injury in children: Definition, epidemiology, and etiology," "Acute kidney injury in children: Clinical manifestations and diagnosis," and "Acute kidney injury in children: Management."
  • Nelson Textbook of Pediatrics - Chapter on Acute Renal Failure.
  • Pediatric Nephrology (Geary & Schaefer) - Comprehensive textbook.

Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. It is not a substitute for professional clinical judgment, diagnosis, or treatment. Clinicians must always consider individual patient circumstances, local protocols, and the most current evidence-based guidelines.